<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Fidelity Aberdeen Street Trust - Advisor Sustainable Target Date 2030 Fund — News on 6ix</title>
    <link>https://6ix.com/company/fidelity-aberdeen-street-trust-advisor-sustainable-target-date-2030-fund-1</link>
    <description>Latest news and press releases for Fidelity Aberdeen Street Trust - Advisor Sustainable Target Date 2030 Fund on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 22 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/fidelity-aberdeen-street-trust-advisor-sustainable-target-date-2030-fund-1" rel="self" type="application/rss+xml" />
    <item>
      <title>Press Release: Sanofi&apos;s Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children</title>
      <link>https://6ix.com/company/fidelity-aberdeen-street-trust-advisor-sustainable-target-date-2030-fund-1/news/press-release-sanofis-tzield-approved-in-the-us-to-delay-the-onset-of-stage-3-type-1-diabetes-in-young-children-4</link>
      <guid isPermaLink="true">https://6ix.com/company/fidelity-aberdeen-street-trust-advisor-sustainable-target-date-2030-fund-1/news/press-release-sanofis-tzield-approved-in-the-us-to-delay-the-onset-of-stage-3-type-1-diabetes-in-young-children-4</guid>
      <pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
      <description>Sanofi&apos;s Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children Expanded approval includes children aged one year and above</description>
    </item>
  </channel>
</rss>